Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Jean‐Pascal Machiels(Cliniques Universitaires Saint-Luc), Yungan Tao(Institut Gustave Roussy), Lisa Licitra(University of Milan), Barbara Burtness(Yale Cancer Center), Makoto Tahara(National Cancer Center Hospital East), Danny Rischin(The University of Melbourne), Gustavo Vasconcelos Alves(Hospital Nossa Senhora da Conceição), Iane Pinto Figueiredo Lima(Centro de Pesquisas Oncológicas), Brett Hughes(The University of Queensland), Y. Pointreau(Centre Jean Bernard), Sercan Aksoy(Hacettepe University Hospital), Simon Laban(University Hospital Ulm), Richard Greil(Paracelsus Medical University), Martin Burian(Ordensklinikum Linz Barmherzige Schwestern), Marcin Hetnał(Andrzej Frycz Modrzewski Krakow University), Jean‐Pierre Delord(Institut Claudius Regaud), Ricard Mesı́a(Institut Català d'Oncologia), Miren Taberna(Institut d'Investigació Biomédica de Bellvitge), John Waldron(University of Toronto), Christian Simon(University of Lausanne), Vincent Grégoire(Centre Léon Bérard), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Ramona F. Swaby(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yayan Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Burak Gümüşçü(Merck & Co., Inc., Rahway, NJ, USA (United States)), Behzad Bidadi(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lillian L. Siu(University of Toronto), Danny Rischin(The University of Melbourne), Brett Hughes(The University of Queensland), Bo Gao, Margaret McGrath, Richard Greil(Paracelsus Medical University), Dietmar Thurnher, Thorsten Fuereder, Martin Burian(Ordensklinikum Linz Barmherzige Schwestern), Sylvie Rottey, Jean‐Pascal Machiels(Cliniques Universitaires Saint-Luc), Paul Clement, Stéphanie Henry, S. Deheneffe, Gustavo Vasconcelos Alves(Hospital Nossa Senhora da Conceição), Iane Pinto Figueiredo Lima(Centro de Pesquisas Oncológicas), Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak(National Cancer Center Hospital East), Andrea Juliana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Mônica Luciana Agostinho Padoan, Ana Paula Victorina, Sérgio Jobim Azevedo, Lillian L. Siu(University of Toronto), Stephanie Yasmin Brule, John Hilton(University of Toronto), Chang Shu Wang, Nathaniel Bouganim, Marc Webster(Andrzej Frycz Modrzewski Krakow University), John Walker(University of Toronto), Neil Chua, Ángela R. Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Alejandro Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Jean‐Pierre Delord(Institut Claudius Regaud), Xavier Zasadny, Lionnel Geoffrois, Yungan Tao(Institut Gustave Roussy), Y. Pointreau(Centre Jean Bernard), Rainer Fietkau, Marlen Haderlein, Andreas Müller, Ursula C. Schroeder, Barbara Wollenberg(Yale Cancer Center), Simon Laban(University Hospital Ulm), Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Aron Popovtzer, Dror Limon, Lisa Licitra(University of Milan), Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nolè, Federica Bertolini, Lorenzo Livi, Maria Grazia Ghi, Ilaria Imarisio, Makoto Tahara(National Cancer Center Hospital East), Akihiro Homma, Tsutomu Ueda, Yukinori Asada, Tomoko Yamazaki, Koji Matsumoto, Takashi Fujii, Sadakatsu Ikeda, Shunji Takahashi, Takashi Kinoshita, Keita Sasaki, Akihito Tsuji, Myung‐Ju Ahn, Byoung Chul Cho, Keun‐Wook Lee, Ki Hyeong Lee, Moon Ki Choi, Hwan‐Jung Yun(Institut Gustave Roussy), Mathijs P. Hendriks, Sjoukje F. Oosting, Jan Buter, Esther van Meerten, Jonathan Graham, Andrzej Kawecki, Izabella Dębicka, Adam Maciejczyk, Maciej Pysz, Dorota Filarska, Marcin Hetnał(Andrzej Frycz Modrzewski Krakow University), P. Koralewski, A. Wygoda, Krzysztof Składowski, Małgorzata Talerczyk, Alfonso Berrocal Jaime, Pedro Pérez Segura, Irene García, Neus Basté Rotllan, R. Mesía Nin(Institut Català d'Oncologia), M. Taberna Sanz(Institut d'Investigació Biomédica de Bellvitge), Lara Iglesias Docampo, Ainara Soria Rivas, Antonio Rueda‐Domínguez, José Manuel Trigo Pérez, Ruey‐Long Hong, Shau-Hsuan Li(University of Toronto), Hung‐Ming Wang, Chia‐Jui Yen, Muh‐Hwa Yang, Yi-Fang Chang, Yi‐Chun Liu, Jin‐Ching Lin, Meltem Ekenel, Hakan Harputluoğlu, Sercan Aksoy(Hacettepe University Hospital), Özgür Özyılkan, Ahmet Bılıcı, Mehmet Alı Nahıt Şendur, Çağatay Arslan, Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Shanmugasundaram Ramkumar, Dorothy M. Gujral, Simon Stewart(University of Lausanne), Melanie Powell, Amen Sibtain, Tom Roques, K. Yip, Arafat Mirza, Muthiah Sivaramalingam, Neil D. Belman, Sanjiv S. Agarwala, Ian C. Anderson(University of Toronto), Arpan Patel, Ronald J. Maggiore, Megan Baumgart, Barbara Burtness(Yale Cancer Center), Mary J. Fidler, Varinder Kaur, Elizabeth Gaughan, Francis P. Worden, Cristina P. Rodriguez, Ammar Sukari, Deborah Jean Lee Wong, Sue S. Yom, William V Walsh, Joseph A. Fiorillo, Jeffrey T. Yorio, Grzegorz S. Obara
Cited by 199Open Access
Abstract
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al.|New England Journal of Medicine|2016|5k